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Aim: Interstitial cystitis/painful bladder syndrome/(IC/PBS) results in recurring pain
in the bladder and surrounding pelvic region caused by abnormal excitability of
micturition reflexes. Spinal cord stimulation (SCS) is currently clinically used for the
attenuation of neuropathic and visceral pain. The present study examinedwhether SCS
at upper lumbar segments modulates detrusor overactivity and visceral hyperalgesia
associated with cystitis in a rat model of cyclophosphamide (CYP)-induced cystitis.
Methods: Cystitis was induced by intraperitoneal injection of CYP (200 mg/kg) in
six adult female Sprague Dawley rats 48 h prior to urodynamic recordings. Another
six rats served as—controls with saline injection. Cystometry and the external
urethral sphincter (EUS) electromyography during bladder infusion were evaluated
under urethane anesthesia. The visceromotor reflexes (VMR) obtained from the
external abdominal oblique muscle were quantified during bladder infusion and
isotonic bladder distension (IBD), respectively. After baseline recordingswere taken,
SCS was applied on the dorsal surface of L3 for 25 min. Urodynamic recordings and
VMR during bladder infusion and IBD were repeated 2 h after SCS.
Results: CYP resulted in detrusor overactivity, stronger EUS tonic contractions, and
increased VMR. SCS significantly reduced non-voiding contractions, prolonged
EUS relaxation, and delayed VMR appearance during bladder infusion as well as
significantly decreased VMR during IBD in cystitis rats.
Conclusion:SCS improvedbladder function andEUSrelaxationduringbladder infusion
and significantly attenuated visceral nociceptive-related VMR during IBD in cystitis rats.
SCS may have therapeutic potential for patients with hyperalgesia and IC/PBS.
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1 | INTRODUCTION
Neuromodulation of the sacral nerves and lumbosacral spinal
roots has been established as an effective treatment for urge
incontinence, urgency-frequency symptoms, non-obstructive
urinary retention, and neurogenic bladder.1 Spinal cord
stimulation (SCS) of upper lumbar segments was previously
reported to improve the urethral relaxation and promote
efficient voiding.2,3 SCS has also been employed for chronic
neuropathic pain and visceral hyperalgesia. The mechanisms
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underlying SCS amelioration of visceral hypersensitivity are
not well understood but may involve both spinal and
supraspinal neural circuits.4,5
Bladder visceral hyperalgesia is often caused by
damage to nociceptors, resulting from inflammation and
cystitis. Cyclophosphamide (CYP)-induced cystitis in
rodents has been used for studying interstitial cystitis/
painful bladder syndrome (IC/PBS) characterized by
pelvic pain, urinary urgency, and urinary frequency.6,7
CYP-treated rodents also show bladder hyperalgesia and
allodynia to noxious bladder distention.6,7 In this study
CYP-induced cystitis is used to evaluate the effect of SCS
at the upper lumbar segment on detrusor overactivity (DO)
and bladder hyperalgesia.
In addition, urethral relaxation is associated with bladder
contractions which is known as detrusor-sphincter coordina-
tion. Efficient voiding critically depends on input from the
urethra. The urethral afferent response to stimulation
activates spinal cord neurons and triggers CNS-mediated
urethral-to-bladder reflexes that contribute to efficient
voiding.8,9 Besides investigating bladder contractions, the
external urethral sphincter (EUS) activity during filling and
voiding is examined before and after SCS.
The urotoxic metabolites of CYP (ie, acrolein)
accumulate in the bladder and urethra, and contribute to
the activation of C-fibers by direct contact with urothe-
lium, leading to detrusor over-activity, and visceral
hyperalgesia. We hypothesize that SCS over the upper
lumbar level could inhibit the activated afferents convey-
ing noxious stimuli from the bladder and urethra.
Therefore, the present study was aimed to investigate
the therapeutic effect of SCS on voiding function, EUS
activation, and visceral nociception in CYP-induced
cystitis rats.
2 | METHODS
All experiments were carried out in accordance with the
National Institutes of Health guidelines and approved by the
Institutional Animal Care and Use Committees at University
of Southern California and University of California Irvine,
CA, USA. Adult female Sprague-Dawley rats (237 ± 6 g,
n= 18, Charles River Laboratories, CA) were housed and
maintained in the animal facility on a 12 h light-dark cycle,
and fed with standard food.
The rats received intraperitoneally (ip) administrated
saline (controls, n= 6) or CYP (cystitis, 200 mg/kg, n= 12)
48 h prior to the urodynamic recordings and SCS. The cystitis
rats were divided into two groups: 1) urodynamic recordings
and visceromotor reflexes (VMR) during bladder infusion
(n= 6) and 2) VMR during isotonic bladder distension (IBD,
n= 6).
2.1 | Surgical preparations for urodynamic
recordings and VMR
Rats received urethane (1.2 g/kg, ip) 1 h prior to surgical
preparations and were then placed on a water-circulating
heating pad to keep the body temperature between 36 and
38°C. A lower abdominal midline incision was made to
expose the bladder and mid-urethra. A PE-50 catheter
(Instech Laboratories, Plymouth Meeting, PA) with the
flared tip was inserted into the top of the bladder dome and
secured using a suture.2,10 The other end of the catheter was
connected to an infusion pump (KD Scientific Inc., Holliston,
MA) and a pressure sensor (Biopac Systems Inc., Goleta, CA)
via a 3-way connector. Two 50 µm insulated silver wire
electrodes with exposed tips were inserted into the mid-
urethra bilaterally, approximately 2 mm from the bladder
neck, to obtain the external urethral sphincter (EUS)
electromyography (EMG). Two additional wire electrodes
with exposed tips were inserted into the external oblique
muscle to record muscle activity associated with visceral
pain-related VMR during isotonic bladder distension. The
pressure sensor and two sets of EMGwires were all connected
to the data acquisition system (MP150, Biopac Systems Inc.)
and data were saved to the computer for data analysis.
2.2 | Surgical preparations for SCS
Laminectomy was performed at the thoracolumbar levels of
T12-L1. The dura over the third lumbar spinal cord segment
(L3) was exposed to place wire electrodes for SCS. After a
small part of the Teflon coating (about 1 mm notch) was
removed from the wires (AS632, Cooner Wire, Chatsworth,
CA), the exposedpart of thewirewas positioned facing the dura
of L3, and then secured as the anode and cathode.2,10 Then, the
muscle and skin layerswere sutured. Thewireswere connected
to a stimulus isolation unit and an electrical stimulator (SIU5
and S88, GRASS Technologies, West Warwick, RI). The
threshold intensity was set as the appearance of EUS bursting
responses, which represents voiding in rodents.2 The stimulat-
ing intensity of SCS was defined at 1.5-2 fold of the threshold
intensity (2.5-4 volts, 40 Hz, and 0.2 msec pulsewidth)without
hind limb muscle twitching.
2.3 | Recording procedures
Baseline urodynamic and VMR parameters during a 30 min
bladder infusion were obtained in the control (n= 6) and
cystitis groups (n= 6) 1 hr after administration of urethane.
The infusion rate was set at 0.1 mL per minute. The urethral
outlet was opened to allow for urine expulsion. Then, the
bladder infusion was stopped and SCS was applied for
25 min. Urodynamic recordings during bladder infusion were
then obtained immediately and 2 h after SCS.
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VMR during IBD (n= 6) was measured by established
methods.11,12 The urethra was occluded to maintain the
desired intravesical pressure (IVP). The bladder was
distended using saline, and the IVP was maintained at 10,
20, 30, and 40 cm H2O for 120 s. Following each IVP level,
the bladder was emptied and allowed to rest for 120 s. After
the VMR baseline was obtained, SCS was applied for 25 min
with an empty bladder. VMR during IBD was then repeated
2 h after SCS.
2.4 | Outcome measurements
The urodynamic and VMR parameters were analyzed during
bladder infusion for three consecutive voiding contractions.
Cystometry measures included: non-voiding contractions that
were larger than15 cmH2Oanddid not result in voided volume,
voiding efficiency, inter-contraction intervals, and residual
volume. Voiding efficiency was calculated as the percentage of
voided volume/total infused volume. The IVP- evoked VMR
was referred to as VMR threshold (cmH2O). The normalized
ratio of VMR threshold/maximum IVP was calculated. EUS-
EMG measurements included the bursting duration during
voiding and the active periods and silent periods during
bursting duration.13 The area under the curve (AUC) of during
IBD VMR was measured at each IVP level.11,12
2.5 | Statistical analysis
All parameters obtained from urodynamic recordings and
VMR are presented as mean values ± standard error.
Comparisons of urodynamic measurements and VMR AUC
between the control and cystitis groups were performed using
the non-parametric Mann-Whitney test. Comparisons of
urodynamic measurements and VMR AUC before and after
SCS were performed using the non-parametric Wilcoxon
matched-paired test. P value < 0.05 indicated statistically
significant difference. GraphPad Prism 6 (GraphPad Soft-
ware, La Jolla, CA) was used to conduct the statistical
analysis and figures.
3 | RESULTS
3.1 | Urodynamic recordings during bladder
infusion
Forty-eight hours after CYP administration, the cystitis rats
(n= 6) showed increased non-voiding contractions
(P= 0.03) compared to controls (n= 6) (Figure 1). These
non-voiding contractions were not affected by acute SCS
(P= 0.38; compared to before SCS). However, the non-
voiding contractions were significantly decreased 2 h after
SCS (P= 0.04; Figure 1). Therefore, the following data
analysis was processed in the controls and cystitis rats before
and 2 h after SCS.
Two hours after SCS, voiding efficiency was decreased in
the cystitis rats (61 ± 5%, n= 6) compared to controls
(91 ± 1%, n= 6) (P= 0.002) (Figure 2). Inter-contraction
intervals in cystitis rats were significantly shorter (97 ± 17 s)
compared to controls (162 ± 21 s,P= 0.048). The normalized
ratio of VMR threshold/maximum IVP in cystitis rats
(74 ± 4%) was significantly lower compared to controls
(87 ± 2%, P= 0.008; Figure 2). The cystitis rats had
significantly higher residual volume (71 ± 15 μL,
P= 0.011) compared to controls (19 ± 5 μL).
The inter-contraction intervals analyzed at 2 h after SCS
were prolonged to 175 ± 29 s (cystitis + SCS, P= 0.046) in
the cystitis rats compared to before SCS (Figure 2). SCS in the
cystitis rats significantly improved voiding efficiency
compared to before SCS (P= 0.03). SCS significantly
reduced the residual volume (35 ± 13 μL) in the cystitis
rats (cystitis + SCS, P= 0.03) compared to the condition
without SCS. SCS significantly delayed the VMR appear-
ance, which is the normalized ratio of VMR threshold/
maximum IVP, in cystitis rats during bladder infusion
(cystitis + SCS, P= 0.03) compared to the condition without
SCS. SCS had no significant effect on urodynamic recordings
and VMR in the control rats.
During bladder filling, tonic EUS-EMG activity gradually
increased and markedly changed to EUS bursting when
FIGURE 1 Representative examples of cystometry during
bladder infusion. The voiding and non-voiding contractions were
more frequent in the cystitis rat compared to the control. The
numbers of non-voiding contractions were decreased immediately
after SCS. Two hours after SCS, the voiding and non-voiding
contractions in cystitis rats were significantly decreased compared to
the cystometry without SCS. Asterisk and arrows indicated voiding
and non-voiding contractions, representatively
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bladder voiding contraction started (Figure 3A). EUS
bursting activity was comprised of active and silent periods
(Figure 3B). The cystitis rats, compared to controls, showed
significant changes including shorter bursting duration
(P= 0.025), prolonged active periods (P= 0.03), and shorter
silent periods (P= 0.04) (Figures 3B and 3C). Two hours
after SCS in the cystitis rats, the bursting duration was
significantly increased (cystitis + SCS, P= 0.03). SCS did
not change the active periods in the cystitis rats; however, the
silent periods were significantly prolonged by SCS (cysti-
tis + SCS, P= 0.03) (Figures 3B and 3C).
3.2 | VMR during IBD
Two hours post SCS, the VMR AUC significantly increased
during IBD at the IVP level of 40 cmH2O in the cystitis rats
compared to controls (P= 0.03) (Figure 4). SCS had no
significant effect in the control rats. SCS significantly
reduced the VMR AUC at the IVP levels of 20, 30, and 40
in the cystitis rats (P= 0.04, 0.03, and 0.03, respectively)
(Figure 4).
4 | DISCUSSION
The present study investigated the effect of SCS at the dorsal
surface of the L3 spinal segment in attempts to modulate DO
and bladder hyperalgesia in rats with CYP-induced cystitis.
CYP-induced cystitis elicited DO as evidenced by increased
non-voiding contractions and shorter inter-contraction inter-
vals. CYP-induced cystitis also induced visceral hyperalgesia
as demonstrated by the increased VMR AUC. SCS
significantly reduced DO, improved voiding function, and
reduced signs of visceral pain in cystitis rats. Previously, SCS
was applied over L3 to induce EUS bursting in the
neurologically intact and spinal cord injured rats, but
cystometry was not investigated.2 Previous studies have
shown that a variety of neuromodulation targets to the sacral
and/or lumbosacral spinal nerves significantly reduce voiding
frequency and/or non-voiding contractions.1,7,14–16 The
present study is the first to demonstrate that CYP-induced
DO is reduced by L3 SCS.
4.1 | Poor voiding efficiency in the cystitis rats
It has been reported that accumulation of acrolein, a
hydroxylated metabolite of CYP, induces irritation of the
urothelium resulting in bladder inflammation.17,18 During
inflammatory reaction, the C-fiber afferents are activated and
elicit detrusor over-activity, resulting in a reduction in bladder
capacity and a consequent increase in contraction fre-
quency.19 CYP-induced cystitis, which is an established
and clinically relevant model of the study of visceral pain.6
The resulting DO causes decreased voiding efficiency and
bladder capacity.20 The present study demonstrated that CYP-
induced cystitis elicited the significant increases of non-
voiding contractions and residual volumes as well as a
FIGURE 2 Statistical analysis of cystometry during bladder infusion in controls (n= 6) and cystitis rats (n= 6) before and 2 hr after SCS. *
and ** indicated the p < 0.05 and p < 0.01, respectively
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significant decrease of inter-contraction intervals as previ-
ously reported.18–20 These changes resulted in poor voiding
efficiency in the cystitis rats compared to controls.
The present study further examined the EUS EMG
activity during filling and voiding in both control and cystitis
groups. EUS bursting in rodents demonstrates intermittent
urethral relaxation and opening of the outlet, which is
essential for achieving efficient voiding.13 In cystitis rats,
there were significant decreases of EUS bursting duration and
silent periods, suggesting a decrease of urethral relaxation. It
is likely this was playing a role in inefficient voiding observed
in the present setting.
4.2 | SCS promoted voiding function
Neuromodulation with SCS does not seem to affect the
normal physiological status in controls. SCS only modulated
the irregular reflex pathways induced by cystitis. Assessment
of DO and urodynamic parameters immediately (ie, 25 min;
Figure 1) after SCS revealed modest changes. However,
assessment of the same parameters 2 h after SCS demon-
strated profound changes. This suggests that the mechanisms
FIGURE 3 EUS EMG activity during bladder infusion in controls and cystitis rats before and 2 h after SCS. EUS EMG activity consisted of
tonic activity during filling and EUS bursting during voiding (A). EUS bursting is composed of active periods and silent periods (B). Statistical
analysis of EUS bursting duration including active and silent periods was shown here (C). The cystitis rats had significant shorter bursting
duration composed of longer active periods and shorter silent periods. SCS had a significant increase in bursting period with longer silent periods
in the cystitis rats (cystitis + SCS). * indicated the P< 0.05
FIGURE 4 Effect of SCS on the visceromotor reflex (VMR)
induced by isotonic bladder distension (IBD). The bladder was
distended using saline from 10 cmH2O to 40 cmH2O. Prior to SCS,
cystitis rats showed a significantly increase in the VMR AUC. Two
hours after SCS, the inhibitory effect on the VMR AUC during IBD
was significantly shown at 20, 30, and 40 cmH2O in the cystitis rats
(cystitis + SCS). + indicated P< 0.05 between the control and cystitis
groups. * indicated the P< 0.05 between the cystitis and
cystitis + SCS groups
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underlying SCS modulation of bladder function are time-
dependent. These could involve changes in synaptic circuits
in the spinal cord involving short term plasticity and/or
peripheral mechanisms. Whether the relief of DO lasts for
longer time was not determined in this study, and future
studies are necessary to test the same parameters at different
times after SCS.
Our previous study indicated that L3 could be the EUS
bursting controlling center in spinal cord injured rats as well
as that SCS over L3 resulted in EUS burstingwith intermittent
urethral relaxation in control rats when the bladder was
partially full.2,10 Here, SCS induced prolonged silent periods
during EUS bursting in the cystitis rats and showed the similar
result of urethral relaxation during voiding.
Combined together, SCS over L3 modulated urethral
relaxation during voiding. SCS seemed to modulate the
lumbosacral spinal neurons receiving inputs from urinary
bladder.2,5,10 Although the urinary bladder and urethra are
mainly innervated via the lumbosacral levels, SCS over L3
may still modulate micturition reflexes by interfering with
signals among the bladder, the lumbosacral spinal cord, and
the pontine micturition center.2,10
4.3 | SCS ameliorates bladder hyperalgesia
Cystitis changes the chemical communication between the
urothelium and C-fiber afferent nerves, resulting in afferent
sensitization. Released neurotransmitters from the irritated
urothelium enhance signaling between the urothelium and
afferent nerves and alter the second-messenger pathways,
triggering painful bladder sensation.21 During saline
infusion to the bladder, the appearance of VMR associated
with voiding contractions was induced earlier in cystitis rats
compared to controls. Furthermore, the bladder was
distended by saline to a constant IVP level between 10 to
40 cmH2O. This range was used to grade mechanical stimuli
of the bladder from innocuous to noxious.12,22 This
hypersensitivity in the cystitis rats was evident by
significantly increased VMR AUC when the IVP reached
the voiding threshold of 40 cmH2O compared to controls.
SCS seems suppressing the C-fiber activity in the CYP-
induced cystitis, but more future investigations are needed
to identify the inhibitory effects.
Our results also showed that the similar effect of SCS
over L3 on the VMR in response to bladder distension in
cystitis rats lasted 2 h. In addition, the effect of SCS over the
upper lumbar cords on the reduced VMR in response to
noxious colonic distention lasted 90 min.4 Recent studies
revealed that SCS increases blood flow via antidromic
activation of sensory afferents to release neuromodulatory
substances at the target organ.23,24 This mechanism may
play a role in the inhibitory effect of SCS on the VMR
induced by bladder distention.
5 | CONCLUSION
In summary, the present study provided a novel method of
SCS over the upper lumbar levels, specifically L3, to
ameliorate DO, modulate urethral intermittent relaxation,
and suppressed cystitis-induced bladder hyperalgesia. The
present rodent model demonstrated the severity of the cystitis
induced by the hazardous chemical irritation. Although it is
not ideal to represent IC/PBS, SCS markedly improved the
voiding function and ameliorated bladder hyperalgesia. This
is a pre-clinical study with limited extrapolation to patients.
Current technologies of SCS are well developed on the
managements of spasticity and neuropathic pain, but are
limited on the visceral pain.25 The mechanisms involved in
suchmodulation of visceral pain by SCS are currently unclear
in both animal and human studies. The present results may
support SCS as a potential therapeutic method for patients
with hyperalgesia and IC/PBS.
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